Cloned Faces with digital background

Whole-Genome Sequencing Comes of Age in Clinical Care

In this Clinical OMICs KEYNOTE webinar, sponsored by Illumina, we are delighted to host two true pioneers of clinical genome sequencing, bioinformatician Dr. Liz Worthey and geneticist Dr. Howard Jacob, who will reflect on a decade of progress in clinical genome analysis and discuss the future challenges confronting the field.
Seattle Wildlife

SARS-CoV-2 Genomic Analysis Reveals January Introduction to Washington State

By analyzing the genomic sequences of SARS-CoV-2 samples from infected patients in Washington State, research suggests that most early infections derive from a single introduction in late January or early February, sparking rapid community transmission of the virus that went undetected for several weeks.
Human liver

Drug-Induced Liver Injury Predicted by Polygenic Risk Score

By combining available genome-wide association study data and applying mathematical weighting methods, the team found a PRS formula that appears to predict which patients may develop DILI as a result of taking different drugs.

NIH Awards $129M in RADx Funding to Nine COVID-19 Test Developers

The latest funding brings to $378 million the total value of contracts awarded to 16 developers of advanced COVID-19 diagnostics through the Rapid Acceleration of Diagnostics (RADx) initiative.
Colon cancer. Cancer attacking cell. Colon disease concept

Natera’s Signatera MRD Test for CRC Gets Local Coverage Decision from CMS

Signatera has been validated across multiple cancer types to detect residual disease as early as two years before standard diagnostic tools, with virtually no false positives on a per sample level, and to help assess treatment response in conjunction with imaging.
Antibodies responding to covid-19 coronavirus, illustration

Roche to Launch Fast Antigen Test To Detect COVID-19 Later this Month

The antigen test is able to detect the presence of proteins associated with SARS-CoV-2 in 15 minutes, which is significantly faster than the standard RT-PCR test that is currently the gold standard for diagnosing COVID-19.

Sherlock’s CRISPR-based SARS-CoV-2 Test Clears First Hurdle in Dartmouth-Hitchcock Pilot

Sherlock’s SARS-CoV-2 test kit has received Emergency use Authorization from the FDA and is designed for use in CLIA labs certified for performing high complexity tests.
Medical bottle with hydroxychloroquine HCQ pills, 3D rendering isolated on white background

Pharmacogenetics Research for COVID-19 Drugs Needed to Improve Patient Safety

Most drugs used for COVID-19 treatments are not being used for the indication they were originally designed for and there has been much public debate about how effective or safe some of them are.

NIH Launches Emerging Infectious Disease Network

The Centers for Research in Emerging Infectious Diseases (CREID) will build a network of multidisciplinary researchers around the world to better understand how viruses and other pathogens make the leap from other living organisms to people.
EEG with electrical activity of abnormal brain, electroencephalogram,EEG

Study Linking Genomic, Phenotypic Data Sheds New Light on Genetics of Childhood Epilepsy

Researcher at the University of Pennsylvania, carried out a computer analysis comparing exome sequencing data from 846 children with epilepsy, who had undergone genomic sequencing as part of previous studies, with phenotypic symptom data from the same individuals.
Scroll Up